Publication | Closed Access

5-(3,4-Difluorophenyl)-3-(6-methylpyridin-3-yl)-1,2,4-oxadiazole (DDO-7263), a novel Nrf2 activator targeting brain tissue, protects against MPTP-induced subacute Parkinson's disease in mice by inhibiting the NLRP3 inflammasome and protects PC12 cells against oxidative stress

MedicineNlrp3 InflammasomeCell DeathPharmacological AgentNeuropharmacologyBrain TissueNeuroprotectionNeurologyNeurosciencePharmacologyOxidative StressNeuroinflammation